Happy Holidays from ISOQOL

Happy Holidays from ISOQOL

2025 is drawing to a close. It has been a year of exciting milestones for ISOQOL, including the first partially hybrid Annual Conference, an increased impact factor for the Journal of Patient-Reported Outcomes, work from the SIG Task Force, and numerous SIG...

Ad Post: EORTC

This is a paid advertisement from EORTC. The European Organisation for Research and Treatment of Cancer (EORTC) is proud to announce the publication of the SISAQOL-IMI consortium’s pivotal paper1 in The Lancet Oncology. In this publication, SISAQOL-IMI, co-led by...

Ad Post: Sprout Health Solutions

Artificial intelligence (AI): Putting the Patient-in-the-Loop The question is no longer whether to use AI but how to use it responsibly. Below, scientists from Sprout Health Solutions explore some of the pros – efficiency and consistency – and cons – bias and...
Happy Holidays from ISOQOL

Happy Holidays from ISOQOL

2024 is drawing to a close. It has been a year of exciting milestones for ISOQOL, including the 31st Annual Conference with a record-breaking number of abstract submissions, the Virtual Measuring What Matters Symposium on social determinants of health, development of...
Happy Holidays from ISOQOL

Happy Holidays from ISOQOL

The ISOQOL Staff will be out of the office for the holidays from 22 December 2023 through 1 January 2024. The International Society for Quality of Life Research (ISOQOL) is a global community of researchers, clinicians, health care professionals, industry...

Ad Post: Unlocking Clarity: Evaluating COAs for Readability

Clinical Outcome Assessments (COAs) are important for evaluating the impact of medical interventions on patients’ well-being and quality of life. To ensure their effectiveness and accuracy, we must consider the readability of these assessments in their...